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Abstract
Background: Central nervous system disease is the most serious form of tuberculosis, and is associated with high
mortality and severe neurological sequelae. Though recent clinical reports suggest an association of distinct
Mycobacterium tuberculosis strains with central nervous system disease, the microbial virulence factors required
have not been described previously.
Results: We screened 398 unique M. tuberculosis mutants in guinea pigs to identify genes required for central
nervous system tuberculosis. We found M. tuberculosis pknD (Rv0931c) to be required for central nervous system
disease. These findings were central nervous system tissue-specific and were not observed in lung tissues. We
demonstrated that pknD is required for invasion of brain endothelia (primary components of the blood-brain
barrier protecting the central nervous system), but not macrophages, lung epithelia, or other endothelia. M.
tuberculosis pknD encodes a “eukaryotic-like” serine-threonine protein kinase, with a predicted intracellular kinase
and an extracellular (sensor) domain. Using confocal microscopy and flow cytometry we demonstrated that the
M. tuberculosis PknD sensor is sufficient to trigger invasion of brain endothelia, a process which was neutralized by
specific antiserum.
Conclusions: Our findings demonstrate a novel in vivo role for M. tuberculosis pknD and represent an important
mechanism for bacterial invasion and virulence in central nervous system tuberculosis, a devastating and
understudied disease primarily affecting young children.
Background
Tuberculosis (TB) of the central nervous system (CNS) is
a devastating and often fatal disease, primarily affecting
young children. Even when treatment is administered in
a timely manner, mortality is extraordinarily high, with
surviving patients often experiencing severe neurological
sequelae. CNS TB comprises approximately 1% of TB
disease worldwide, disproportionately affecting children
in developing nations [1]. Coinfection with human
immunodeficiency virus increases the likelihood of CNS
TB [2,3], and the emergence of drug resistant strains
further complicates CNS TB due to limited permeability
at the blood-brain barrier (BBB) of several second-line
TB drugs. Delays in treatment due to drug-susceptibility
testing further reduce the efficacy of available patient
care [4].
The CNS is protected from the systemic circulation by
the BBB, composed principally of specialized and tightly
apposed brain microvascular endothelia (BMEC), sup-
ported by astrocyte processes [5,6]. According to the
widely accepted hypothesis by Rich et al (1933), lesions
(Rich foci) develop around bacteria seeded in the brain
parenchyma and meninges during the initial hematogen-
ous dissemination. Subsequent rupture of these foci results
in the release of bacteria directly into the CSF, causing
extensive inflammation and meningitis [7]. The onset of
meningitis is most commonly observed in young children
(between the ages of 0 and 4), and is also associated with
HIV co-infection or recent corticosteroid use [8]. In addi-
tion to host risk factors, recent clinical reports have indi-
cated the association of distinct Mycobacterium
tuberculosis strains with CNS disease [9-12], and microbial
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numerous other neuroinvasive pathogens [13]. While it is
clear that M. tuberculosis invade the CNS and that micro-
bial factors may be required for CNS disease, the identity
of such virulence determinants remains elusive.
We previously described a murine model of CNS TB
utilizing hematogenous dissemination to the CNS, and
identified M. tuberculosis genes required for CNS disease
[14]. We developed a similar model of CNS TB in the gui-
nea pig, which, unlike mice, develop well-defined, necrotic
granulomas in response to M. tuberculosis infection [15],
and were also utilized by Rich et al for their seminal work
on CNS TB [7]. By screening and characterizing several
hundred M. tuberculosis transposon (Tn) mutants, we
identified M. tuberculosis pknD as a key microbial factor
required for CNS disease.
Results
M. tuberculosis genes required for CNS disease
Guinea pigs were infected by intravenous injection of 1 ×
10
6 M. tuberculosis. Animals become moribund and suc-
cumb to pulmonary and disseminated disease 24-28 days
after such an infection, thus 21 days was chosen as the
end-point for our mutant screens. Whole brain CFU were
reliably > 1 × 10
4 CFU at day 21.
398 genotypically-defined M. tuberculosis Tn disruption
mutants, each with a disruption in a single gene were
screened (Additional file 1). The mutant output pool
(bacilli harvested from lungs and brains at day 21) was
compared to input pool (bacilli harvested from blood on
the day of infection). Mutants attenuated in the CNS were
also tested for their survival phenotype in the lung tissue.
Of the 398 mutants analyzed, 14 were found to exhibit
CNS-specific attenuation (> 16 fold). No corresponding
defects were observed for these mutants in lung tissue (< 4
fold attenuation) (Table 1). Similar results were obtained
when attenuation in the brain was compared with lung tis-
sues (instead of blood on the day of infection). One of the
14 mutants identified in the screen, M. tuberculosis pknD
(Rv0931c), was highly attenuated in the guinea pig brain,
and was also identified to have a CNS-specific phenotype
in our previously reported work utilizing the murine
model [14]. Polar effects on the predicted operon partner
pstS2 are not expected, as pknD is located downstream of
pstS2. Additionally, nearby downstream genes are oriented
in the opposite direction to pknD.
To verify our results from the pooled infections, we
tested the M. tuberculosis pknD mutant individually.
Mice were intravenously infected with M. tuberculosis
wild-type or pknD mutant strains and sacrificed at days 1
and 49 following infection. Equal numbers of the
M. tuberculosis wild-type and pknD mutant strains were
implanted at day 1 in the brain (2.58 ± 0.07 and 2.52 ±
0.07 log10 CFU; P = 0.61) and lungs (4.98 ± 0.14 and
5.06 ± 0.15 log10 CFU; P = 0.50) respectively (Figure 1A).
Note that even though a modest invasion defect is
expected for the pknD mutant, the in vivo models are not
powered to reliably observe these modest differences at
day 1, which, however, are amplified by day 49. The M.
tuberculosis pknD mutant was significantly attenuated for
survival in the brain (18.7 fold), compared to the wild-type
strain (P = 0.004), but not in the lung tissue (Figure 1A).
Taken together with our observations during pooled infec-
tion in both mice and guinea pigs, these data indicate a
Table 1 M. tuberculosis genes found to be associated with CNS invasion/survival in the guinea pig
Gene MT # Gene Rv # Description P value
MT0086 Rv0079 Conserved Hypothetical Protein 5.87E-04
MT0350 Rv0336 Conserved 13E12 Repeat Family Protein 1.99E-03
MT0752 Rv0727c Possible Aldolase 5.07E-04
MT0779 Rv0755c PPE Family Protein 1.25E-04
MT0958 Rv0931c Ser-Thr Protein Kinase (PknD) 1.65E-03
MT1311 Rv1273c Probable Drug-Transport ABC Transporter 2.71E-04
MT1711 Rv1673c Conserved Hypothetical Protein ND
MT1965 Rv1914c Conserved Hypothetical Protein ND
MT1982 Rv1932 Probable Thiol Peroxidase Tpx 4.47E-05
MT2456 Rv2387 Conserved Hypothetical Protein 2.53E-04
MT3178 Rv3094c Conserved Hypothetical Protein ND
MT3247 Rv3159c PPE Family Protein 5.87E-05
MT3321 Rv3224 Iron-Regulated Dehydrogenase/Reductase 2.77E-03
MT3461 Rv3353c Conserved Hypothetical Protein 9.12E-03
Mutants for the above genes were found to be significantly attenuated in the guinea pig CNS, but not lungs, 21 days after intravenous infection. Selected
mutants were attenuated greater than 16-fold in the CNS and less than 4-fold in the lung tissue (P < 0.05). Mutants annotated as “ND” were not detected in the
brain in quantities detectable by PCR, and were therefore likely highly attenuated in CNS tissue.
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mutant.
M. tuberculosis pknD is necessary for invasion of
CNS-derived endothelia
To determine whether the observed phenotype was due
to a specific interaction with host cells likely to encoun-
ter M. tuberculosis in CNS or lung tissues, invasion
assays were performed in activated J774 macrophages
and non-professional phagocytic cells [CNS-derived
BMEC (HBMEC), A549 alveolar basal epithelial cells,
and umbilical vein endothelia (HUVEC)]. HUVEC and
A549 were chosen as they represent the most commonly
used endothelial and pulmonary epithelial cells, respec-
tively, employed for pathogen studies. Infections were
performed with M. tuberculosis wild-type, pknD mutant,
or a strain which was complemented with the pknD/
pstS2 operon. Strain CQ0688, an intergenic M. tubercu-
losis Tn mutant, was used as a negative control, while
M. tuberculosis Rv0442c mutant, known to be attenu-
ated in macrophages [16], was used as a positive control
for macrophage experiments. The pknD mutant demon-
strated an invasion defect in HBMEC after 90 minutes
of infection (P = 0.02), a defect restored by complemen-
tation (Figure 1B). These results were confirmed in
three independent experiments. Invasion of A549 or
Figure 1 Invasion and survival of M. tuberculosis pknD mutant in host-derived cells. A. BALB/c mice were infected with M. tuberculosis
CDC1551 or pknD mutant, and sacrificed at days 1 and 49 after infection. The mutant for M. tuberculosis pknD was significantly attenuated (P =
0.004) in mouse brain, but not lung tissue, 49 days after infection. No defect was observed in the lungs at either time point. Bacterial burden is
represented as log10 CFU/organ for all animal experiments. B. Invasion of host-cell monolayers by wild-type CDC1551, wild-type intergenic
transposon control, pknD transposon mutant (pknD:Tn), and pknD genetic complement (pknD:Comp) was examined and normalized to the wild-
type control. Invasion assays were performed in brain microvascular endothelial cells (HBMEC), epithelial A549 cells, and umbilical vein endothelia
(HUVEC). No difference in invasion was observed in A549 cells (P = 0.31) or HUVEC (P = 0.41). A significant reduction in invasive capacity,
however, was observed in the CNS-derived HBMEC (P = 0.02). This defect was restored by genetic complementation with the native pknD/pstS2
operon. N.S. = not significantly different. C. Intracellular survival of each of the above M. tuberculosis strains was examined in HBMEC at days 1, 3,
5, and 7 after infection. The pknD:Tn mutant demonstrated an invasion and intracellular survival defect in HBMEC relative to wild-type over the
course of the seven day infection. D. Survival was also examined by infection of activated J774 macrophages. No corresponding survival defect
for the pknD:Tn mutant was observed in these cells during the seven day infection. A mutant for the gene Rv0442c, known to be attenuated in
the macrophage model, is included as a control. All CFU counts are represented as mean ± standard deviation.
Be et al. BMC Microbiology 2012, 12:7
http://www.biomedcentral.com/1471-2180/12/7
Page 3 of 12HUVEC by the pknD mutant was not significantly lower
than that of wild-type (Figure 1B).
Since macrophages are the key host cells that interact
with M. tuberculosis in the lungs, bacterial survival assays
were also performed to assess the role of pknD in activated
J774 macrophages. Host cells were lysed and bacteria cul-
tured at days 0, 1, 3, 5, and 7 following infection. Bacterial
counts for the pknD mutant remained below that of wild
type bacteria in HBMEC at days 3 (P = 0.008), 5 (P =
0.03), and 7 (P = 0.003) during the course of the infection
(Figure 1C). When accounting for the reduced invasion at
day 0, an intracellular survival defect was still observed at
d a y s5( P=0 . 0 3 )a n d7( P=0 . 0 3 ) .N oc o r r e s p o n d i n g
defect was observed for the pknD mutant at any time
point in macrophages (Figure 1D). These data indicate
that the CNS-associated defect of the pknD mutant may
be due to defective invasion and survival in brain
endothelia.
The PknD extracellular domain is sufficient to trigger
adhesion and invasion of brain endothelia
In order to determine whether the presence of PknD pro-
tein is sufficient for invasion, fluorescent microspheres
were coated with either recombinant PknD sensor or
bovine serum albumin (BSA). Host cell actin cytoskeleton
was stained with Alexafluor 488-Phalloidin. Coated micro-
spheres were incubated with brain endothelia (HBMEC)
for 90 minutes, followed by extensive washing. Confocal
microscopy demonstrated that higher numbers of PknD-
coated microspheres adhered to HBMEC than in the case
of BSA-coated control microspheres (Figure 2A-B). Addi-
tionally, the PknD-coated microspheres were largely
embedded within indentations of actin and near sites of
actin protrusion (Figure 2C). Several microspheres were
visually confirmed to be intracellular after the inoculation
(Figure 2D). A significant increase in fluorescence was
observed in wells containing PknD-coated microspheres
relative to those containing their BSA-coated counterparts
(P = 0.0002) (Figure 2E). Adherence of PknD-coated
microspheres (but not BSA-coated microspheres) to
HBMEC was significantly reduced by pre-incubation with
anti-PknD serum, when compared to incubation with
naïve antiserum (P = 0.005) (Figure 2F).
In order to determine whether microspheres were invad-
ing and present intracellularly, the above incubations were
repeated, and cells analyzed by flow cytometry. We
observed that, in samples incubated with PknD-coated
microspheres, 7.7 ± 0.4% of HBMEC contained fluorescent
spheres, while only 0.6 ± 0.2% of cells incubated with
BSA-coated microspheres were positive for fluorescence
(Figure 3A-C). Microspheres were again incubated with
anti-PknD serum, and internalization by HBMEC was sig-
nificantly reduced when compared to incubation with naïve
serum (P = 0.001) (Figure 3D). Together, these data
indicate that M. tuberculosis PknD is sufficient to trigger
uptake by brain endothelia.
M. tuberculosis pknD mutant exhibits reduced adherence
to a component of the host ECM
Since M. tuberculosis PknD sensor is homologous to
proteins that bind to the host ECM, we measured the
adherence of M. tuberculosis pknD mutant to major
components of the ECM using laminin, collagen, and
fibronectin matrices generated in vitro. The M. tubercu-
losis pknD mutant demonstrated a reduction in associa-
tion with the in vitro laminin matrix (P = 0.001), but
not to collagen or fibronectin matrices (Figure 4A).
Endothelia secrete laminin to generate a matrix for
adhesion and maintenance of cell structure. To deter-
mine whether PknD protein associates with laminin
secreted by brain endothelia, PknD-coated microspheres
were incubated with HBMEC and stained for host lami-
nin. It was observed that, relative to BSA-coated micro-
spheres, PknD-coated microspheres were more likely to
localize with the laminin-stained HBMEC (Figure 4B-C).
Invasion of brain endothelial cells by M. tuberculosis is
reduced by anti-PknD serum
Following observations that anti-PknD serum reduces
adhesion and invasion of PknD-coated microspheres,
similar experiments were performed using live M. tuber-
culosis. M. tuberculosis exposed to PknD-specific antibo-
dies at a dilution of 1:250 were significantly attenuated
in their ability to invade the brain endothelium relative
to those bacteria incubated with naïve serum (P =
0.004) (Figure 5).
Discussion
Recent clinical studies have observed the association of
M. tuberculosis strains with CNS disease [9-12], and
suggest that M. tuberculosis may possess virulence fac-
tors which promote CNS involvement. M. leprae ML-
LBP21, for instance (a major surface protein), has been
shown to be involved in Schwann cell invasion via lami-
nin-2 [17], while M. tuberculosis malate synthase has
been shown to bind ECM associated with A549 cells
[18]. Additionally, the heparin-binding hemagglutinin of
M. tuberculosis has been shown to be required for
extra-pulmonary dissemination [19].
We utilized both the guinea pig and mouse models of
hematogenous dissemination to the CNS in this study.
In previous experiments with single strain infections, we
have regularly observed a high degree of bacillary inva-
sion of the guinea pig CNS. When performing an intra-
venous infection, we can reliably reproduce conditions
where greater than 50,000 bacilli are present in the
brain over a 3 week infection. Whole brain CFU in the
mouse after an intravenous infection are lower than in
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infections when 100 mutants are simultaneously injected
as we need an adequate total bacillary burden to provide
sufficent numbers of each individual mutant. A burden
of 50,000, for instance, would yield approximately 500
bacilli for each mutant. If only 50 bacilli were present
(as may be seen in the mouse model), we would likely
not be able to draw definite conclusions. This was not a
concern during single mutant infections, as only one
strain was present. We therefore used the mouse, which
Figure 2 M. tuberculosis PknD is sufficient to trigger adhesion to HBMEC. A and B. Fluorescent microspheres were coated with either PknD
sensor or BSA, inoculated into HBMEC, washed, and stained for actin. Confocal microscopy demonstrated that PknD sensor-coated microspheres
(panel B) adhere to brain endothelia to a greater degree than those coated with BSA (panel A). C. Confocal images were assembled into a 3D
reconstruction and examined under higher magnification. PknD sensor-coated microspheres appear to be largely enveloped by actin processes
(arrows) indicating that PknD-induced uptake by host cells may be an active process. D. When confocal images are examined in multiple planes,
it is clear that a number of microspheres exist intracellularly. E. Wells containing endothelial cells with microspheres were analyzed for
fluorescence. Quantification of fluorescence demonstrated a significant increase in the adherence of PknD-coated microspheres to the
monolayer (P = 0.0002). F. Microspheres were pre-incubated with either custom anti-PknD serum or naïve serum. Incubation with anti-PknD
serum (1:250 dilution) significantly reduced adherence of PknD (P = 0.0007) but not BSA-coated microspheres (P = 0.6). Moreover, no reduction
in adherence was noted for PknD or BSA-coated microspheres when incubated with naïve antiserum (BSA: P = 0.4; PknD: P = 0.1; ANOVA single
factor). Fluorescence readings are presented as mean ± standard deviation. *Statistically significant difference.
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BSA-coated fluorescent microspheres, washed, and disrupted by trypsinization. Endothelia were subjected to flow cytometry and gated to
remove extracellular microspheres not associated with whole cells. B. Flow cytometry analysis demonstrated that significantly more endothelial
cells were positive for fluorescence when incubated with PknD sensor-coated microspheres compared to BSA-coated microspheres (7.7% vs.
0.6%; P = 0.0003). Cell counts are presented as mean ± standard deviation. C. Histograms show that discrete fluorescent-positive populations are
evident in the cells inoculated with PknD sensor-coated microspheres, indicating that cell populations took up multiple quantities of
microspheres. D. Microspheres were again pre-incubated with either custom anti-PknD serum or naïve serum, followed by inoculation onto
endothelial cells. Pre-incubation with anti-PknD (1:250) significantly reduced the population of cells which were positive for fluorescent
microspheres, compared to naïve serum, as is indicated in the figure by a horizontal bar (P = 0.001). Pre-incubation with anti-PknD (1:1250) had
no effect on internalization, when compared to untreated cells (P = 0.07).
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performing the single strain infections. An additional
benefit of using multiple animal systems is the validation
provided by replicating our findings in several in vivo
models. As described above, the M. tuberculosis pknD
mutant was found to be highly attenuated in both ani-
mal models.
Since the CNS is protected from the systemic circula-
tion by the BBB, M. tuberculosis can initiate CNS TB by
crossing the BBB as extracellular organisms or via
infected monocytes or neutrophils. While the latter
hypothesis seems attractive, such cellular traffic is
severely restricted across the barrier before the onset of
TB meningitis [20]. Moreover, patients with CNS TB and
meningitis have extensive blood vessel involvement and
significant endovasculitis with the intima (comprising
brain endothelia) most severely affected [21]. Goldzieher
et al. have further shown that M. tuberculosis can be
found inside brain endothelia of patients with TB menin-
gitis [22]. Seminal work by Rich et al, later confirmed by
MacGregor and colleagues, demonstrated that free
M. tuberculosis can invade the CNS [7,23]. More modern
data utilizing CD18-/- leukocyte adhesion deficient mice
suggest that free mycobacteria can traverse the BBB inde-
pendent of leukocytes or macrophages [24]. These data
emphasize the central role of brain endothelia in the
pathogenesis of CNS TB and underscore the importance
of our observation that the pknD mutant displayed
Figure 4 M. tuberculosis PknD sensor domain interacts with host laminin. A. M. tuberculosis WT and pknD mutant were incubated in wells
coated with components of the extracellular matrix (laminin, fibronectin, and collagen). The pknD mutant demonstrated a 2-fold reduction in
adhesion to the laminin matrix (P = 0.001), while not exhibiting significantly reduced adhesion to fibronectin or collagen. CFU counts are
represented as mean ± standard deviation. N.S. = not significantly different. B and C. Coated microspheres were incubated with HBMEC,
followed by immunostaining for laminin. Microspheres coated with PknD sensor (panel C) associated with the periphery of laminin staining
more than those coated with BSA (panel B), which were evenly distributed throughout the field of view.
Be et al. BMC Microbiology 2012, 12:7
http://www.biomedcentral.com/1471-2180/12/7
Page 7 of 12defective invasion and reduced survival in brain endothe-
lia. While endothelial cells are not professionally phago-
cytic, they are capable of mounting an antibacterial
response through the release of antimicrobial peptides.
Activation of endothelial barriers can also trigger bacter-
ial killing via NO- or H2O2-dependent pathways [25,26].
It is possible that disruption of pknD disables a bacterial
response pathway necessary for survival in these unique
conditions, resulting in the reduced intracellular growth
we observed during infection of brain endothelial cells.
Reduced invasion was not observed in other cells pre-
viously utilized to evaluate invasion and dissemination
defects of M. tuberculosis mutants and clinical strains
[19,27]. However, one of the limitations of the current
study is that other CNS cell types such as microglia and
astrocytes, which could play a role in mycobacterial
infection and killing in vivo, were not evaluated.
M. tuberculosis pknD encodes a “eukaryotic-like”
STPK, a family of bacterial signaling proteins. STPKs
occur in numerous pathogenic bacteria, and M. tubercu-
losis encodes 11 putative STPKs (pknA-L). Good et al
have demonstrated that the M. tuberculosis PknD sensor
is composed of a highly symmetric six-bladed b-propeller
forming a cup with a functional binding surface [28]. The
b-propeller is a widespread motif found mostly in eukar-
yotes, although it was first described in influenza virus
neuraminidase [29]. Takagi et al have shown that nido-
gen, a b-propeller-containing protein in humans which is
homologous to the sensor domain of M. tuberculosis
PknD, is required for binding to laminin [30]. Similarly,
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Figure 5 Invasion of brain endothelia by M. tuberculosis is reduced by anti-PknD serum. M. tuberculosis CDC1551 were pre-incubated with
naïve or custom anti-PknD serum, washed, and used to infect brain endothelial cells. Following 90 minutes of infection, cells were lysed and CFU
enumerated. It was observed that incubation with anti-PknD serum, but not naïve serum, significantly reduced the number of bacilli able to
successfully invade HBMEC (P = 0.01). *Statistically significant difference.
Be et al. BMC Microbiology 2012, 12:7
http://www.biomedcentral.com/1471-2180/12/7
Page 8 of 12Trypanosoma cruzi, a protozoan pathogen that causes
meningoencephalitis in humans, has a PknD homolog
(Tc85-11), also possessing a b-propeller, that selectively
binds to laminin [31]. In accordance with bioinformatics
predictions, M. tuberculosis PknD has been identified as
an integral membrane protein in several proteomics stu-
dies [32,33]. We therefore hypothesized that the PknD
sensor domain could be assisting in bacterial adherence
by association with host ECM components, and our in
vitro data are consistent with this hypothesis. Moreover,
since brain endothelia associate principally with laminin
1 and 2, not present in epithelia and endothelia elsewhere
[13,34,35], we postulate that the observed CNS tropism
of pknD may be due to its interaction with CNS-asso-
ciated laminin isoforms.
Bacterial STPKs are candidates for sensing the environ-
ment and regulation of microbial metabolic states
[36,37]. The M. tuberculosis PknD intracellular kinase
has been previously demonstrated to associate with and
phosphorylate intracellular targets including MmpL7 [38]
and the putative anti-anti-sigma factor Rv0516c, regulat-
ing sigF-associated genes [39]. M. tuberculosis sigF is an
alternative sigma factor implicated in stress response, sta-
tionary phase, dormancy, and late-stage disease in vivo
[40,41]. Our previously published data demonstrate that
M. tuberculosis significantly down-regulate transcription,
protein synthesis, and energy metabolism very early after
invasion by brain endothelia [42]. These data raise the
possibility that interaction with the host CNS may med-
iate bacterial signaling. Thet w od o m a i ns t r u c t u r eo f
PknD invites the hypothesis that an extracellular signal,
possibly a host factor, may induce an intracellular cas-
cade via activity of the kinase and regulation of sigF.A n
ortholog of M. tuberculosis pknB in Bacillus subtilis has
been demonstrated to regulate bacterial dormancy by a
similar mechanism [43,44]. The potential induction of
sigF-mediated cellular activity via pknD could confer
upon M. tuberculosis a survival advantage in unique con-
ditions such as the brain endothelium.
M. tuberculosis are well known to adapt to a quiescent
dormant state. However, the precise location of dormant
bacilli during human latent TB infection remains elusive.
Immune surveillance of foreign antigens is relatively lim-
ited in the CNS [20,45], and mycobacteria escape immune
recognition following direct inoculation into the brain par-
enchyma [46]. We therefore postulate that the unique
microenvironment in the CNS is advantageous for bacter-
ial survival, and may provide a sanctuary to dormant
M. tuberculosis. While this study examines and indicates a
role for M. tuberculosis pknD in the initial stages of inva-
sion and infection, the role of dormancy in CNS disease
will be an active area of research for our future studies.
Given the above data, we hypothesize that interaction
of PknD protein with a host extracellular factor, possibly
laminin, facilitates adhesion of M. tuberculosis to the
microvascular endothelium of the CNS. Other neurotro-
pic pathogens have been shown to trigger host-mediated
uptake and internalization of bacteria through cytoskele-
tal rearrangement, thus this represents a possible
mechanism for future study [47,48]. Given the multi-
domain structure of PknD, extracellular engagement of
the sensor domain could transduce a signal to the intra-
cellular kinase, triggering a bacterial state, possibly dor-
mancy, which is more amenable to uptake and survival
in the microenvironment of the CNS.
It should also be noted that the PknD sensor domain
occurs only in pathogenic mycobacteria, and is present in
all sequenced clinical strains. Polymorphisms in the pknD
gene or its promoter could therefore account for variable
CNS tropism of distinct lineages of M. tuberculosis.S t u -
dies evaluating polymorphisms in M. tuberculosis isolated
from patients with CNS or pulmonary disease are cur-
rently underway and may shed light on the clinical rele-
vance of pknD or other such genes potentially involved
with promoting CNS TB. Finally, it is important to note
that bacterial invasion of host cells could be neutralized by
an antibody raised against the extracellular (sensor)
domain of M. tuberculosis PknD. This is encouraging and
suggests a potential role for PknD as a therapeutic target
against CNS TB.
Conclusions
We have identified several M. tuberculosis genes which
play a role in CNS TB, and have discovered a novel biolo-
gical function for M. tuberculosis pknD in CNS disease.
Our findings were associated with CNS tissue, and were
not observed in the lungs. We further found that pknD is
required for invasion of cells lining the brain endothelium,
and that the M. tuberculosis PknD sensor is sufficient to
trigger invasion of brain endothelia. This process was neu-
tralized by specific antiserum, which demonstrates promis-
ing therapeutic potential. These data present a unique and
novel role for this serine-threonine protein kinase. Knowl-
edge gained from further study of pknD, and other candi-
dates identified in this study, may lead to the development
of preventive strategies for CNS TB, a devastating and
under-studied disease. Moreover, these studies may also
shed light on extra-pulmonary reservoirs for dormant
M. tuberculosis.
Materials and methods
M. tuberculosis strains and media
M. tuberculosis CDC1551 parent and mutant strains were
grown at 37°C in 7H9 liquid broth (Difco) supplemented
with oleic acid albumin dextrose catalase (BD), 0.5% gly-
cerol, and 0.05% Tween 80. Mutants for pooled infections
were grown in sealed 24 well plates. For colony counting,
M. tuberculosis strains were plated onto Middlebrook
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complemented using the gene sequence corresponding to
pstS2 and pknD (predicted operon), as well as 200 base
pairs upstream of pstS2 to ensure inclusion of the full
native pknD promoter. This sequence was cloned into
plasmid pGS202, a single copy integrating plasmid, and
transformed into the pknD Tn mutant.
Pooled guinea pig infections
Mutant selection and pooled mutant infections were per-
formed as described previously [14]. A pool complexity of
100 was used. Each pooled suspension was diluted to an
OD600 of 0.1 in PBS and 200 uL injected intravenously
into each of four Hartley guinea pigs (catheterized) corre-
sponding to 1 × 10
6 bacilli per animal. Blood was obtained
immediately following infection and cultured. Following
21 days of infection, guinea pigs were euthanized and per-
fused with saline. Blood, lungs, and whole brain were har-
vested, homogenized, and cultured. Bacterial colonies
were pooled, and genomic DNA extracted.
Quantitative PCR analyses
The frequency of individual mutants in each organ was
assessed by qPCR (Bio-Rad) with mutant-specific primers
spanning the transposon insertion junction. Samples were
normalized to results from a set of primers amplifying a
mutant-independent DNA sequence (sequence from
Rv0986). Attenuation for each mutant in the CNS or lungs
was expressed as the ratio of an individual mutant’s quan-
tity present in the input pool (blood sample immediately
after infection) compared with the output pool (brain or
lung sample 21 days after infection). All assays were per-
formed at least in triplicate.
Single mutant infection in the murine model
BALB/c mice were intravenously infected with 1 × 10
6
wild-type or pknD mutant strains, via the tail vein. Four
animals were sacrificed for each group at days 1 and 49.
Blood, lungs, and brain were extracted, homogenized, and
cultured on 7H11 selective plates (BD) and colony forming
units (CFU) obtained 4 weeks after sacrifice.
Tissue culture and ex vivo infection
Primary human brain microvascular endothelial cells
(HBMEC) were isolated, characterized and purified from
the cerebral cortex of a 9 month old infant (IRB exempt)
as previously described [49-51]. Cells were grown in
RPMI 1640 media supplemented with 10% fetal bovine
serum, 10% Nu Serum, L-glutamine, sodium pyruvate,
MEM nonessential amino acids, and MEM vitamins as
described previously [42]. J774 macrophages were grown
in RPMI 1640 supplemented with 10% fetal bovine
serum. Human umbilical vein endothelia (HUVEC) were
g r o w ni nE B M - 2b a s a lm e d i ac o n t a i n i n gE G M - 2M V
SingleQuot supplements (Lonza). A549 cells were grown
in DMEM supplemented with 10% FBS.
Infection of HBMEC with M. tuberculosis for invasion
and intracellular survival assays was performed in triplicate
at a multiplicity of infection (MOI) of 10:1 as described
previously [14]. Macrophages were activated by addition
of interferon-g (IFN-g) one day prior to infection and lipo-
polysaccharide (LPS) three hours prior to infection. The
subsequent assay was then performed according to the
same protocol used for HBMEC. Cells were inspected at
each time point to ensure integrity of the monolayer, and
extracellular bacteria were washed away prior to lysis of
cells. Additionally, low levels of streptomycin were main-
tained in the media in order to preclude the possibility of
extracellular growth.
For assays involving neutralization with antisera, bacteria
were incubated with either naïve (pre-bleed) or anti-PknD
serum for 60 minutes. Bacteria were subsequently washed
in PBS and used for infections.
Production and detection of PknD protein
The coding sequence for PknD amino acid residues 403-
664 was cloned into pDEST17 (6 × N-terminal his-tag)
using the Gateway cloning system (Invitrogen). Expression
of PknD protein was induced using 0.1% L-arabinose at
37°C in BL21-AI E. coli. PknD protein was purified by
SDS-PAGE and used to generate custom polyclonal anti-
serum in rabbits (Covance).
Preparation and use of fluorescent microspheres
Protein was immobilized on 4 μm red fluorescent micro-
spheres (Invitrogen). Recombinant PknD sensor domain
protein or bovine serum albumin (BSA) were incubated
with microspheres in phosphate buffered saline (PBS) at
25°C, using BSA as a blocking agent. Microspheres were
a d d e da taM O Io f1 : 1a n di n c u b a t e df o r9 0m i n u t e sa t
37°C and 5% CO2. Fluorescence readings (excitation
540 nm; emission 590 nm) were taken before and after
washing. For flow cytometry, cells were trypsinized and
processed on a FACSCalibur flow cytometer (BD). In the
antiserum neutralization studies, microspheres were incu-
bated with naïve serum (pre-bleed sera) or anti-pknD
serum for 60 minutes, followed by washing and incubation
with cells as described above. For confocal microscopy,
cells were fixed in 4% formaldehyde and permeabilized.
For actin staining, cells were incubated with Alexa Fluor-
488 conjugated phalloidin (Invitrogen). For laminin immu-
nostaining, cells were incubated with rabbit polyclonal
antibody against murine laminin (Sigma-Aldrich) followed
by FITC conjugated goat anti-rabbit IgG (Invitrogen).
Adhesion to the extracellular matrix (ECM)
Laminin from EHS cells (laminin-1) (Sigma-Aldrich),
fibronectin (Sigma-Aldrich), collagen (Invitrogen), or
Be et al. BMC Microbiology 2012, 12:7
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96-well ELISA plates (Greiner) at 25°C overnight in
order to coat wells with a protein matrix. M. tuberculo-
sis were incubated in these wells at 37°C for 90 minutes.
Wells were washed, and the protein matrices disrupted
by incubation with 0.05% trypsin. The suspensions were
plated onto 7H11 plates.
Statistical analysis
Statistical comparison between groups was performed
using Student’s t test and Microsoft Excel 2007. Multi-
ple comparisons were performed using ANOVA single
factor test and the Microsoft Excel 2007 Analysis Tool-
pak Add-in.
All protocols were approved by the Johns Hopkins
University Biosafety and Animal Care and Use
committees.
Additional material
Additional file 1: M. tuberculosis transposon disruption mutants
screened for attenuation in the guinea pig model of central
nervous system tuberculosis. 398 transposon mutants were selected
for pooled infection in the guinea pig model. Each mutant listed was
screened for attenuation in the central nervous system.
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